<unk>  has a high potential for drug interactions. In terms of effects of<unk>  on other drugs, the exposure of substrates of CYP3A4, CYP2C19, CYP2C9, UDP-glucuronosyltransferase, P-glycoprotein, ABCG2, or OATP1B1 may be reduced to varying extents. In terms of effects of other drugs on<unk> , strong CYP2C8 or CYP3A4 inhibitors may increase levels of<unk>  or its major active metabolite N-desmethylapalutamide, while mild to moderate CYP2C8 or CYP3A4 inhibitors are not expected to affect their exposure.
Apalutamide
Darolutamide
Bicalutamide
Nilutamide
Acetothiolutamide
Topilutamide
Flutamide
Enzalutamide